ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 400938 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 400938; 2) Community: the network communities that were significantly associated with the response to NSC 400938; 3) Molecule: the relationships between components within communities and NSC 400938; 4) MDR: the compounds that were significantly associated with the NSC 400938.

NSC Compound Enrichment Correlation
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0392716453377535 0.092438124
NSC 709974 Null 0.0392716453377535 0.18375254
NSC 717468 Null 0.0392716453377535 0.18755994
NSC 717953 Null 0.0392716453377535 0.065198283
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 0.020173088
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0392716453377535 0.26704831
NSC 722996 2-(4-chloro-benzyl)-1H-naphth[2,3-d]imidazole 0.0392716453377535 0.062450511
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.20802565
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0392716453377535 0.0196885
NSC 732205 Null 0.0392716453377535 0.1897588
Total:81  Current:66    [First] [Prev] [Next] [Last]